These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 28829833

  • 1. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK, Chang J, Kim HJ, Jeong SH.
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [Abstract] [Full Text] [Related]

  • 2. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB, Zain NM, Bruce KD, Burr LD, Chen AC, Rivett DW, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [Abstract] [Full Text] [Related]

  • 3. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ.
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS.
    Am J Respir Crit Care Med; 2013 May 15; 187(10):1118-26. PubMed ID: 23348972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.
    Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA, White SR.
    J Allergy Clin Immunol; 2016 May 15; 137(5):1398-1405.e3. PubMed ID: 26627545
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.
    Masekela R, Vosloo S, Venter SN, de Beer WZ, Green RJ.
    BMC Pulm Med; 2018 May 22; 18(1):87. PubMed ID: 29788934
    [Abstract] [Full Text] [Related]

  • 12. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.
    Choo JM, Abell GCJ, Thomson R, Morgan L, Waterer G, Gordon DL, Taylor SL, Leong LEX, Wesselingh SL, Burr LD, Rogers GB.
    mSphere; 2018 Apr 25; 3(2):. PubMed ID: 29669883
    [Abstract] [Full Text] [Related]

  • 13. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J, McNally P, John B, DeSantis T, Linnane B, Murphy P, SHIELD CF.
    PLoS One; 2014 Apr 25; 9(12):e109798. PubMed ID: 25526264
    [Abstract] [Full Text] [Related]

  • 14. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P, Jary H, Perry A, Perry JD, Stewart CJ, Nelson A, Lanyon C, Smith DL, Cummings SP, De Soyza A.
    BMC Microbiol; 2014 May 20; 14():130. PubMed ID: 24886473
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.
    Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB.
    J Clin Microbiol; 2014 Oct 20; 52(10):3605-13. PubMed ID: 25078910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA, AERIS Study Group.
    Thorax; 2018 May 20; 73(5):422-430. PubMed ID: 29386298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.